Fitzy: Pharmacology of Rheumatoid Arthritis Flashcards

1
Q

What kinds of drugs do we use for RA?

A

-immunosuppressive drugs because it’s an autoimmoune rxn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Biologyical agents used

A
  • Anti TNGa

- Anti IL-1 antibodies/antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Signal modulation

A

-Janus kinase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Disease modifying Rheumatic drugs (DMARDS)

A
  • methotrexate: inhibits Dihydrfoloate reductase
  • Hydroxychoroquine
  • sulfasalzine
  • leflunamide: inhibits dihydroorotate dehydrogenase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the frontline DMARD of choice for mild to moderate RA?

A

-Low dose methotrexate (MTX)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When does MTX become most active?

A
  • when it gets polyglutamated within cells
  • takes 25-30 weeks to reach steady state
  • takes time to achieve a plateau effect of clinical response with MTX
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does MTX (glu)n inhibit?

A
  • AICAR TFase: so no more F-AICAR

- DHFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

If AICAR can’t get turned into F-AICAR, what happens to it?

A
  • it turns into adenosine
  • then, that activates purinergic/adenosine G ptn receptors… anti inflammatory effect
  • this is the anti inflammatory part
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the result of DHFR being suppressed?

A
  • no more THF production
  • so no more thymidine and purines… they get depleted
  • this is the anti proliferative part
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the better route for administration of MTX?

A

-parenteral because it increases bioavailabitily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what do we have to keep track of in the patient if we are going to use MTX?

A
  • their renal function
  • 80-90% of MTX is cleared via kidneys
  • it will build up…. adverse effects… booo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What toxicities are associated with MTX?

A
  • hepatotoxicity: so do liver function tests
  • pulmonary damage
  • myelosuppression
  • *this is more common with high dose therapy for cancer, but do occur with low dose therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What else should all people taking MTX take?

A
  • folic acid daily
  • or folinic acid weekly
  • to prevent hematologic side effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does withdrawal of MTX lead to?

A
  • flare of RA within three to six weeks

- clearance of MTX(glu)n

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do glucocorticoids do?

A
  • repress transcription of genes encoding inflammatory cytokine and COX-2
  • *** so the repress the NFKB transcription factor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When should we use pulse glucocorticoid therapy?

A

-treatment of acute flares of RA

17
Q

adverse effects of glucocorticoids

A
  • osteoporosis

- diabetegenic (bolded)

18
Q

What are the different corticosteroids we can use?

A
  • Prednisone: oral
  • Methylprednisolone: IM
  • Traimcinolone and hexacetonide: intra-articular
19
Q

What two cytokine things are involved with RA?

A
  • TNF alpha

- IL-1

20
Q

What is the 100% humanized solube TNF receptor?

A
  • etanercept
  • binds to TNF…
  • “CEPT” for reCEPTor
21
Q

Anti TNF monoclonal antibodies

A
  • infliximab: mouse TNF binding and human IgG1

- Adalimumab (100%) humanized: human TNF binding and human IgG1

22
Q

What is Anakinra?

A
  • inhibits IL-1

- receptor antagonist

23
Q

What are the safety issues with anti-TNF alpha agents?

A
  • increase the risk for serious infections
  • TB!!!
  • pneumocytic carinii if CD4 count is <100
24
Q

what is Certolizumab pegol?

A

-a pegylated humanized antibody Fab fragment of tumor necrosis factor alpha monoclona antibody

25
Q

What is golimumab?

A
  • human monoclonal antibody that binds to human tumor necrosis factor alpha (TNF a)
  • sq 1x per month
26
Q

What do we give adults who have RA if they have an inadequate response to, or are intolerant of, MTX?

A

-Tofacitinib

27
Q

What is Tofacitinib?

A
  • an oral Janus activated kinase (JAK) inhibitor that is a targeted immunomodulator and disease-modifying therapy for RA
  • it’s unique because it has an intracellular target: JAK
28
Q

What do we have to be careful with when using Tofacitinib?

A

-don’t have any immunizations without your doctor’s approval